Regie Lyn Santos-Cortez
Concepts (386)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otitis Media | 17 | 2025 | 171 | 9.230 |
Why?
| | Hearing Loss | 26 | 2023 | 235 | 5.070 |
Why?
| | Genes, Recessive | 27 | 2021 | 78 | 3.160 |
Why?
| | Mutation, Missense | 16 | 2024 | 340 | 2.830 |
Why?
| | Pedigree | 54 | 2025 | 511 | 2.760 |
Why?
| | alpha-Macroglobulins | 6 | 2024 | 25 | 2.480 |
Why?
| | Deafness | 7 | 2023 | 78 | 2.410 |
Why?
| | Microbiota | 10 | 2023 | 768 | 2.390 |
Why?
| | Genetic Variation | 12 | 2025 | 1000 | 2.360 |
Why?
| | Ear, Middle | 8 | 2024 | 84 | 2.160 |
Why?
| | Genetic Predisposition to Disease | 25 | 2025 | 2375 | 2.150 |
Why?
| | Mutation | 27 | 2023 | 4015 | 1.750 |
Why?
| | Migraine Disorders | 2 | 2025 | 107 | 1.530 |
Why?
| | Consanguinity | 21 | 2024 | 49 | 1.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 1.300 |
Why?
| | Cochlear Implantation | 3 | 2021 | 76 | 1.270 |
Why?
| | Sequence Analysis, DNA | 16 | 2020 | 825 | 1.160 |
Why?
| | Cochlear Implants | 3 | 2020 | 91 | 1.140 |
Why?
| | Vertigo | 2 | 2025 | 53 | 1.080 |
Why?
| | Membrane Proteins | 9 | 2021 | 1158 | 1.060 |
Why?
| | RNA, Ribosomal, 16S | 5 | 2023 | 558 | 1.050 |
Why?
| | Exome | 17 | 2023 | 238 | 1.030 |
Why?
| | Gene Frequency | 8 | 2019 | 494 | 0.900 |
Why?
| | Nasopharynx | 2 | 2022 | 74 | 0.870 |
Why?
| | Palatine Tonsil | 1 | 2024 | 55 | 0.870 |
Why?
| | Vestibular Diseases | 1 | 2025 | 53 | 0.870 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 165 | 0.820 |
Why?
| | Pakistan | 17 | 2024 | 77 | 0.820 |
Why?
| | Otitis Media, Suppurative | 2 | 2024 | 4 | 0.810 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 98 | 0.800 |
Why?
| | Intellectual Disability | 3 | 2023 | 173 | 0.790 |
Why?
| | Aortic Aneurysm, Thoracic | 8 | 2016 | 136 | 0.780 |
Why?
| | Alleles | 8 | 2019 | 891 | 0.770 |
Why?
| | Meniere Disease | 1 | 2023 | 35 | 0.770 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.740 |
Why?
| | Child | 26 | 2025 | 22414 | 0.730 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 13 | 0.710 |
Why?
| | Haemophilus Infections | 1 | 2022 | 41 | 0.710 |
Why?
| | Genotype | 17 | 2023 | 1866 | 0.710 |
Why?
| | Connexins | 6 | 2016 | 52 | 0.690 |
Why?
| | Down-Regulation | 2 | 2024 | 641 | 0.690 |
Why?
| | Child, Preschool | 16 | 2025 | 11512 | 0.690 |
Why?
| | Temporal Bone | 1 | 2021 | 44 | 0.680 |
Why?
| | Membrane Transport Proteins | 4 | 2017 | 156 | 0.680 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.670 |
Why?
| | Male | 65 | 2025 | 70179 | 0.660 |
Why?
| | Plasminogen | 1 | 2020 | 33 | 0.660 |
Why?
| | Mentoring | 1 | 2023 | 154 | 0.660 |
Why?
| | Scoliosis | 1 | 2023 | 221 | 0.650 |
Why?
| | Humans | 85 | 2025 | 141754 | 0.640 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 317 | 0.630 |
Why?
| | Otitis Media with Effusion | 1 | 2019 | 20 | 0.630 |
Why?
| | Female | 64 | 2025 | 75943 | 0.620 |
Why?
| | ABO Blood-Group System | 1 | 2019 | 53 | 0.610 |
Why?
| | Philippines | 5 | 2019 | 51 | 0.590 |
Why?
| | Genetic Markers | 3 | 2018 | 343 | 0.580 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 313 | 0.580 |
Why?
| | Mice, Knockout | 3 | 2024 | 3071 | 0.560 |
Why?
| | Mice | 15 | 2025 | 18109 | 0.550 |
Why?
| | Acid Ceramidase | 1 | 2017 | 2 | 0.540 |
Why?
| | Keloid | 1 | 2017 | 8 | 0.540 |
Why?
| | Albinism, Oculocutaneous | 1 | 2017 | 5 | 0.530 |
Why?
| | Ear, Inner | 3 | 2016 | 52 | 0.520 |
Why?
| | Homozygote | 9 | 2018 | 201 | 0.520 |
Why?
| | Genes, Duplicate | 1 | 2016 | 4 | 0.520 |
Why?
| | Down Syndrome | 1 | 2023 | 506 | 0.500 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2016 | 15 | 0.490 |
Why?
| | Genetic Linkage | 13 | 2018 | 288 | 0.480 |
Why?
| | Hearing Loss, Sensorineural | 4 | 2021 | 68 | 0.480 |
Why?
| | Animals | 20 | 2025 | 37749 | 0.470 |
Why?
| | Adolescent | 21 | 2025 | 22130 | 0.460 |
Why?
| | Haplotypes | 8 | 2019 | 499 | 0.460 |
Why?
| | Hair Cells, Auditory | 2 | 2021 | 39 | 0.460 |
Why?
| | Gene Duplication | 1 | 2015 | 65 | 0.460 |
Why?
| | Neurodevelopmental Disorders | 1 | 2018 | 210 | 0.460 |
Why?
| | DNA, Bacterial | 1 | 2016 | 339 | 0.450 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4421 | 0.420 |
Why?
| | Phenotype | 14 | 2021 | 3177 | 0.420 |
Why?
| | Adenylyl Cyclases | 1 | 2014 | 63 | 0.420 |
Why?
| | Lysine-tRNA Ligase | 1 | 2013 | 2 | 0.410 |
Why?
| | Lod Score | 11 | 2016 | 64 | 0.400 |
Why?
| | Myosins | 3 | 2021 | 137 | 0.400 |
Why?
| | Cyclic AMP | 1 | 2014 | 219 | 0.400 |
Why?
| | Genetic Loci | 6 | 2014 | 277 | 0.380 |
Why?
| | Chromosomes, Human, Pair 19 | 2 | 2016 | 28 | 0.370 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1771 | 0.370 |
Why?
| | Environmental Exposure | 1 | 2016 | 585 | 0.350 |
Why?
| | Retinitis Pigmentosa | 2 | 2023 | 20 | 0.350 |
Why?
| | Adult | 23 | 2024 | 39391 | 0.330 |
Why?
| | Otoscopy | 2 | 2023 | 8 | 0.320 |
Why?
| | Chromosomes, Human, Pair 4 | 2 | 2006 | 32 | 0.310 |
Why?
| | Polymorphism, Single Nucleotide | 7 | 2025 | 2135 | 0.310 |
Why?
| | Finland | 2 | 2019 | 81 | 0.310 |
Why?
| | Polydactyly | 2 | 2019 | 11 | 0.300 |
Why?
| | Codon, Nonsense | 4 | 2018 | 43 | 0.300 |
Why?
| | Genetic Association Studies | 6 | 2019 | 375 | 0.300 |
Why?
| | Family Health | 6 | 2019 | 194 | 0.300 |
Why?
| | Toes | 2 | 2019 | 16 | 0.300 |
Why?
| | Amino Acid Sequence | 9 | 2020 | 2158 | 0.290 |
Why?
| | Fingers | 2 | 2019 | 106 | 0.280 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 3 | 2017 | 6 | 0.280 |
Why?
| | Genes, Dominant | 2 | 2011 | 97 | 0.270 |
Why?
| | Connexin 26 | 5 | 2014 | 8 | 0.260 |
Why?
| | Sequence Analysis, RNA | 2 | 2020 | 450 | 0.260 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 5909 | 0.250 |
Why?
| | COS Cells | 2 | 2018 | 183 | 0.250 |
Why?
| | Genomics | 3 | 2020 | 815 | 0.240 |
Why?
| | Logistic Models | 2 | 2025 | 2092 | 0.240 |
Why?
| | Frameshift Mutation | 3 | 2015 | 32 | 0.230 |
Why?
| | Exons | 5 | 2018 | 353 | 0.230 |
Why?
| | Molecular Sequence Data | 7 | 2016 | 2929 | 0.220 |
Why?
| | Molecular Epidemiology | 1 | 2005 | 72 | 0.220 |
Why?
| | Cohort Studies | 5 | 2025 | 5815 | 0.220 |
Why?
| | Infant | 7 | 2021 | 9843 | 0.220 |
Why?
| | Case-Control Studies | 4 | 2025 | 3597 | 0.220 |
Why?
| | Dizziness | 1 | 2025 | 94 | 0.220 |
Why?
| | Bacteria | 2 | 2022 | 881 | 0.220 |
Why?
| | Serine Endopeptidases | 2 | 2018 | 127 | 0.220 |
Why?
| | Fasting | 1 | 2006 | 284 | 0.210 |
Why?
| | HEK293 Cells | 4 | 2023 | 737 | 0.210 |
Why?
| | Cochlea | 2 | 2015 | 71 | 0.210 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 93 | 0.210 |
Why?
| | Models, Molecular | 4 | 2016 | 1604 | 0.200 |
Why?
| | Intracranial Aneurysm | 2 | 2016 | 100 | 0.200 |
Why?
| | Chromosome Mapping | 8 | 2019 | 504 | 0.200 |
Why?
| | Zebrafish | 4 | 2016 | 504 | 0.190 |
Why?
| | Faculty | 1 | 2023 | 154 | 0.180 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 5697 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 157 | 0.180 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2016 | 547 | 0.180 |
Why?
| | ADAMTS1 Protein | 1 | 2021 | 2 | 0.180 |
Why?
| | Carboxy-Lyases | 1 | 2021 | 9 | 0.180 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.180 |
Why?
| | RNA Splice Sites | 2 | 2018 | 50 | 0.170 |
Why?
| | Mentors | 1 | 2023 | 212 | 0.170 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2021 | 50 | 0.170 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2019 | 467 | 0.170 |
Why?
| | Oncogene Proteins | 1 | 2021 | 63 | 0.170 |
Why?
| | Base Sequence | 2 | 2015 | 2180 | 0.170 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.170 |
Why?
| | DNA Demethylation | 1 | 2020 | 3 | 0.160 |
Why?
| | Mouth | 1 | 2020 | 88 | 0.160 |
Why?
| | Dioxygenases | 1 | 2020 | 33 | 0.160 |
Why?
| | Lipoxygenase | 2 | 2017 | 18 | 0.160 |
Why?
| | Ichthyosis, Lamellar | 2 | 2017 | 9 | 0.160 |
Why?
| | Young Adult | 9 | 2020 | 13749 | 0.150 |
Why?
| | Chronic Disease | 2 | 2024 | 1820 | 0.150 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 605 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2023 | 1027 | 0.150 |
Why?
| | Ciliopathies | 1 | 2018 | 6 | 0.150 |
Why?
| | Acute Disease | 2 | 2019 | 1010 | 0.150 |
Why?
| | Protein Conformation | 3 | 2020 | 941 | 0.150 |
Why?
| | Saliva | 1 | 2020 | 251 | 0.150 |
Why?
| | Tumor Suppressor Proteins | 1 | 2021 | 326 | 0.150 |
Why?
| | Chromosome Segregation | 1 | 2018 | 47 | 0.140 |
Why?
| | Arthrogryposis | 2 | 2015 | 15 | 0.140 |
Why?
| | Hypotrichosis | 1 | 2018 | 1 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 353 | 0.140 |
Why?
| | Ichthyosis | 1 | 2018 | 13 | 0.140 |
Why?
| | Genetic Diseases, Inborn | 1 | 2018 | 47 | 0.140 |
Why?
| | RNA Splicing Factors | 1 | 2018 | 57 | 0.140 |
Why?
| | Polymorphism, Genetic | 3 | 2005 | 625 | 0.140 |
Why?
| | Nails, Malformed | 1 | 2017 | 7 | 0.140 |
Why?
| | Skin Diseases, Genetic | 1 | 2017 | 13 | 0.140 |
Why?
| | DEAD-box RNA Helicases | 1 | 2018 | 86 | 0.140 |
Why?
| | 3' Untranslated Regions | 1 | 2018 | 149 | 0.140 |
Why?
| | Cytoskeletal Proteins | 2 | 2015 | 156 | 0.140 |
Why?
| | Middle Aged | 11 | 2020 | 34647 | 0.140 |
Why?
| | Family | 2 | 2018 | 680 | 0.130 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 255 | 0.130 |
Why?
| | Optic Atrophy | 1 | 2016 | 8 | 0.130 |
Why?
| | Rare Diseases | 1 | 2017 | 112 | 0.130 |
Why?
| | Developmental Disabilities | 1 | 2020 | 284 | 0.130 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 1 | 2016 | 26 | 0.130 |
Why?
| | Dystonic Disorders | 1 | 2016 | 27 | 0.130 |
Why?
| | Population Groups | 1 | 2016 | 58 | 0.120 |
Why?
| | Trichothiodystrophy Syndromes | 1 | 2016 | 1 | 0.120 |
Why?
| | Marfan Syndrome | 2 | 2016 | 43 | 0.120 |
Why?
| | Fibrillin-1 | 1 | 2016 | 6 | 0.120 |
Why?
| | Recurrence | 1 | 2019 | 1111 | 0.120 |
Why?
| | Integrin beta Chains | 1 | 2015 | 7 | 0.120 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2016 | 14 | 0.120 |
Why?
| | Alopecia | 1 | 2015 | 32 | 0.120 |
Why?
| | Tooth Abnormalities | 1 | 2015 | 14 | 0.120 |
Why?
| | Keratins, Type I | 1 | 2015 | 1 | 0.120 |
Why?
| | Sphingosine | 1 | 2016 | 45 | 0.120 |
Why?
| | Autistic Disorder | 2 | 2020 | 210 | 0.120 |
Why?
| | Blood Glucose | 1 | 2006 | 2278 | 0.120 |
Why?
| | Hair Diseases | 1 | 2015 | 10 | 0.120 |
Why?
| | Activating Transcription Factor 6 | 1 | 2015 | 20 | 0.120 |
Why?
| | Color Vision Defects | 1 | 2015 | 9 | 0.120 |
Why?
| | Coatomer Protein | 1 | 2015 | 3 | 0.120 |
Why?
| | Precision Medicine | 1 | 2019 | 434 | 0.120 |
Why?
| | Lysophospholipids | 1 | 2016 | 80 | 0.120 |
Why?
| | Lipase | 1 | 2015 | 68 | 0.120 |
Why?
| | Mitral Valve Insufficiency | 1 | 2016 | 73 | 0.120 |
Why?
| | Methionine Adenosyltransferase | 1 | 2014 | 10 | 0.110 |
Why?
| | Muscle Hypotonia | 1 | 2015 | 33 | 0.110 |
Why?
| | Contracture | 1 | 2015 | 21 | 0.110 |
Why?
| | Transglutaminases | 1 | 2015 | 156 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2016 | 200 | 0.110 |
Why?
| | Golgi Apparatus | 1 | 2015 | 100 | 0.110 |
Why?
| | Hair | 1 | 2015 | 89 | 0.110 |
Why?
| | Chromosomes, Human, Pair 16 | 2 | 2014 | 36 | 0.110 |
Why?
| | Autoantigens | 1 | 2017 | 426 | 0.110 |
Why?
| | Sodium Channels | 1 | 2015 | 63 | 0.110 |
Why?
| | Transcriptome | 1 | 2021 | 1014 | 0.110 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2016 | 162 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 198 | 0.110 |
Why?
| | Moyamoya Disease | 1 | 2014 | 21 | 0.110 |
Why?
| | Genetic Heterogeneity | 1 | 2014 | 58 | 0.110 |
Why?
| | Prevalence | 2 | 2016 | 2799 | 0.110 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2016 | 450 | 0.110 |
Why?
| | RNA Splicing | 1 | 2016 | 270 | 0.110 |
Why?
| | Arthritis | 1 | 2015 | 104 | 0.110 |
Why?
| | Labyrinth Supporting Cells | 1 | 2014 | 3 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3737 | 0.110 |
Why?
| | Extremities | 1 | 2015 | 140 | 0.110 |
Why?
| | Carrier Proteins | 2 | 2018 | 748 | 0.100 |
Why?
| | Microsatellite Repeats | 3 | 2018 | 159 | 0.100 |
Why?
| | Cyclic GMP-Dependent Protein Kinase Type I | 1 | 2013 | 3 | 0.100 |
Why?
| | Transfer RNA Aminoacylation | 1 | 2013 | 2 | 0.100 |
Why?
| | Tetraspanins | 1 | 2013 | 19 | 0.100 |
Why?
| | Aging, Premature | 1 | 2013 | 16 | 0.100 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2013 | 14 | 0.100 |
Why?
| | Fatty Acids | 1 | 2016 | 450 | 0.100 |
Why?
| | Leukoencephalopathies | 1 | 2013 | 19 | 0.100 |
Why?
| | Face | 1 | 2015 | 175 | 0.100 |
Why?
| | Language Development Disorders | 1 | 2013 | 39 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4190 | 0.100 |
Why?
| | Cytoplasm | 1 | 2014 | 273 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 175 | 0.100 |
Why?
| | Chickens | 1 | 2013 | 189 | 0.100 |
Why?
| | Cell Line | 1 | 2018 | 2887 | 0.100 |
Why?
| | Sequence Deletion | 1 | 2013 | 183 | 0.100 |
Why?
| | Neoplasm Proteins | 2 | 2017 | 434 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2016 | 439 | 0.100 |
Why?
| | Computational Biology | 2 | 2018 | 664 | 0.100 |
Why?
| | GPI-Linked Proteins | 1 | 2012 | 78 | 0.100 |
Why?
| | Proteins | 1 | 2018 | 1015 | 0.090 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 36 | 0.090 |
Why?
| | Claudins | 1 | 2012 | 24 | 0.090 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2011 | 17 | 0.090 |
Why?
| | Smad3 Protein | 1 | 2011 | 44 | 0.090 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2011 | 75 | 0.090 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 2013 | 28 | 0.090 |
Why?
| | Population Surveillance | 1 | 2014 | 482 | 0.090 |
Why?
| | Syndrome | 2 | 2015 | 378 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2015 | 465 | 0.080 |
Why?
| | Quality of Life | 1 | 2023 | 3014 | 0.080 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 280 | 0.080 |
Why?
| | Retrospective Studies | 2 | 2025 | 16374 | 0.080 |
Why?
| | Acyltransferases | 2 | 2023 | 76 | 0.080 |
Why?
| | Mitochondria | 1 | 2016 | 979 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2608 | 0.080 |
Why?
| | Heterozygote | 2 | 2014 | 308 | 0.080 |
Why?
| | Epilepsy | 1 | 2014 | 349 | 0.080 |
Why?
| | Software | 1 | 2014 | 678 | 0.070 |
Why?
| | DNA Mutational Analysis | 3 | 2017 | 398 | 0.070 |
Why?
| | Lung Diseases, Interstitial | 1 | 2015 | 654 | 0.070 |
Why?
| | Audiometry | 2 | 2005 | 31 | 0.070 |
Why?
| | Signal Transduction | 2 | 2019 | 5169 | 0.070 |
Why?
| | Protein Domains | 2 | 2021 | 304 | 0.060 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 1 | 2006 | 11 | 0.060 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2006 | 16 | 0.060 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2006 | 20 | 0.060 |
Why?
| | Audiometry, Pure-Tone | 1 | 2006 | 32 | 0.060 |
Why?
| | Jordan | 1 | 2005 | 5 | 0.060 |
Why?
| | Auditory Threshold | 1 | 2006 | 46 | 0.060 |
Why?
| | Sequence Analysis, Protein | 1 | 2005 | 31 | 0.060 |
Why?
| | Chromosome Aberrations | 1 | 2006 | 160 | 0.060 |
Why?
| | Risk Factors | 2 | 2016 | 10482 | 0.060 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2005 | 46 | 0.060 |
Why?
| | Netherlands | 1 | 2005 | 87 | 0.060 |
Why?
| | Population Dynamics | 1 | 2006 | 153 | 0.060 |
Why?
| | Conserved Sequence | 1 | 2005 | 238 | 0.050 |
Why?
| | Hypopituitarism | 1 | 2023 | 16 | 0.050 |
Why?
| | Linear Models | 1 | 2006 | 858 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2006 | 502 | 0.050 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1406 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 876 | 0.050 |
Why?
| | Nuclear Proteins | 2 | 2018 | 719 | 0.050 |
Why?
| | Calcium-Binding Proteins | 2 | 2014 | 217 | 0.050 |
Why?
| | United States | 1 | 2019 | 15310 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2005 | 510 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2006 | 792 | 0.040 |
Why?
| | Sequence Homology | 1 | 2020 | 43 | 0.040 |
Why?
| | Fibroblasts | 2 | 2016 | 1021 | 0.040 |
Why?
| | Growth Disorders | 1 | 2020 | 87 | 0.040 |
Why?
| | Movement Disorders | 1 | 2020 | 65 | 0.040 |
Why?
| | Aged | 4 | 2016 | 24746 | 0.040 |
Why?
| | Embryonic Development | 1 | 2020 | 118 | 0.040 |
Why?
| | Nucleotide Mapping | 1 | 2018 | 3 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2016 | 4212 | 0.040 |
Why?
| | Disease Progression | 1 | 2006 | 2800 | 0.040 |
Why?
| | Sjogren-Larsson Syndrome | 1 | 2017 | 1 | 0.030 |
Why?
| | Ichthyosis Vulgaris | 1 | 2017 | 1 | 0.030 |
Why?
| | Porphyria, Variegate | 1 | 2017 | 1 | 0.030 |
Why?
| | Protoporphyrinogen Oxidase | 1 | 2017 | 1 | 0.030 |
Why?
| | Flavoproteins | 1 | 2017 | 8 | 0.030 |
Why?
| | Photosensitivity Disorders | 1 | 2017 | 8 | 0.030 |
Why?
| | 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2017 | 3 | 0.030 |
Why?
| | INDEL Mutation | 1 | 2017 | 17 | 0.030 |
Why?
| | Epidermolysis Bullosa Simplex | 1 | 2017 | 10 | 0.030 |
Why?
| | Keratin-14 | 1 | 2017 | 15 | 0.030 |
Why?
| | Xeroderma Pigmentosum | 1 | 2017 | 8 | 0.030 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2017 | 27 | 0.030 |
Why?
| | Intermediate Filament Proteins | 1 | 2017 | 58 | 0.030 |
Why?
| | Endonucleases | 1 | 2017 | 32 | 0.030 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2017 | 19 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2018 | 111 | 0.030 |
Why?
| | Collagen Type VII | 1 | 2017 | 28 | 0.030 |
Why?
| | Blister | 1 | 2017 | 40 | 0.030 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2017 | 42 | 0.030 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1485 | 0.030 |
Why?
| | Periodontal Diseases | 1 | 2017 | 60 | 0.030 |
Why?
| | Muscular Diseases | 1 | 2017 | 113 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 2016 | 66 | 0.030 |
Why?
| | Epidermolysis Bullosa | 1 | 2017 | 67 | 0.030 |
Why?
| | Stereocilia | 1 | 2016 | 8 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2903 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1712 | 0.030 |
Why?
| | Cameroon | 1 | 2016 | 7 | 0.030 |
Why?
| | Physical Chromosome Mapping | 2 | 2006 | 20 | 0.030 |
Why?
| | Basal Ganglia | 1 | 2016 | 57 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2014 | 2828 | 0.030 |
Why?
| | Phospholipases | 1 | 2015 | 16 | 0.030 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2015 | 21 | 0.030 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2015 | 55 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2016 | 94 | 0.030 |
Why?
| | Adipokines | 1 | 2016 | 52 | 0.030 |
Why?
| | Cataract | 1 | 2018 | 223 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 122 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2005 | 5212 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 261 | 0.030 |
Why?
| | Craniofacial Dysostosis | 1 | 2015 | 3 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2015 | 73 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 94 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 391 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2016 | 533 | 0.030 |
Why?
| | Hepatocyte Growth Factor | 1 | 2014 | 35 | 0.030 |
Why?
| | Introns | 1 | 2016 | 254 | 0.030 |
Why?
| | Gene Rearrangement | 1 | 2015 | 151 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2016 | 232 | 0.030 |
Why?
| | Ion Channels | 1 | 2015 | 130 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 118 | 0.030 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2016 | 260 | 0.030 |
Why?
| | Vascular Remodeling | 1 | 2016 | 196 | 0.030 |
Why?
| | Sample Size | 1 | 2014 | 128 | 0.030 |
Why?
| | Adenosine Triphosphatases | 1 | 2014 | 159 | 0.030 |
Why?
| | GTPase-Activating Proteins | 1 | 2014 | 85 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2013 | 28 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 1057 | 0.030 |
Why?
| | Protein Transport | 1 | 2015 | 448 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2013 | 91 | 0.030 |
Why?
| | Disease | 1 | 2014 | 102 | 0.030 |
Why?
| | Osteogenesis | 1 | 2015 | 199 | 0.020 |
Why?
| | Heart Valve Diseases | 1 | 2014 | 153 | 0.020 |
Why?
| | Aorta | 1 | 2016 | 424 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 265 | 0.020 |
Why?
| | Retina | 1 | 2015 | 314 | 0.020 |
Why?
| | Genome, Human | 1 | 2014 | 421 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2012 | 56 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2014 | 377 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 556 | 0.020 |
Why?
| | Ribose-Phosphate Pyrophosphokinase | 1 | 2011 | 1 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 529 | 0.020 |
Why?
| | Aortic Valve | 1 | 2014 | 359 | 0.020 |
Why?
| | Age of Onset | 1 | 2013 | 534 | 0.020 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2011 | 42 | 0.020 |
Why?
| | Neuropeptides | 1 | 2011 | 77 | 0.020 |
Why?
| | Models, Genetic | 1 | 2013 | 592 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1492 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2013 | 435 | 0.020 |
Why?
| | Glycoproteins | 1 | 2011 | 358 | 0.020 |
Why?
| | Computer Simulation | 1 | 2013 | 1015 | 0.020 |
Why?
| | Actins | 1 | 2011 | 424 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2011 | 859 | 0.020 |
Why?
| | Trans-Activators | 1 | 2011 | 394 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2011 | 632 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2576 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1243 | 0.020 |
Why?
| | India | 1 | 2006 | 208 | 0.010 |
Why?
| | Brain | 1 | 2013 | 2868 | 0.010 |
Why?
|
|
Santos-Cortez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|